« Inevitable or avoidable? Despite the lessons of history, the world is not yet ready to face the next great plague | Main | How much avian flu vaccine does Africa need? »

Bookmark in Connotea

Production technologies change flu vaccine landscape

Standfirst: Mamalian cell culture for the production of seasonal flu vaccine finally gains approval. Does this mark the end of a decades old tradition of using hens’ eggs?

See the full story here

Posted by Julie Clayton on July 23, 2007
Categories: | | Comments (0) | TrackBacks (0)

TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/3088

Post a comment

Comments will be reviewed by the blog editors before being published, mainly to ensure that spam and irrelevant material (such as product advertisements) are not published . Please keep your comment brief. Excessively long or offensively phrased entries will be edited.

We strongly encourage you to use your real, full name. E-mail addresses are required in case we need to discuss your comment with you directly. We won't publish your e-mail address unless you request it.

Please enter the numbers you see below - this helps us to avoid spam. If you are having trouble with this system, you can send your comment by e-mail to 'avianflu at nature.com'.

please enter code